WHO
What Purpose Unitaid’s Patent Pool?
Wednesday, June 16, 2010
This paper examines the wisdom of Unitaid's new patent pool for AIDS treatments, considering the weaknesses in the case for such a pool, the lessons from historical examples and the likely consequences for research and development.
Producing Medicines for Chronic Diseases in Less Developed Countries
Thursday, June 10, 2010
The HIV / AIDS crisis bears a number of clinical and practical similarities to the new challenge of producing drugs to treating chronic disease in lower-income countries, providing a useful case study when determining effective strategies. A new literature review by Philip Stevens, the second in a three-part series, examines what can be learned from the global response to HIV / AIDS – and reveals some costly mistakes that should not be repeated.
Report Calls Tuberculosis 'Neglected Sister'
IPN News coverage
Philip Stevens discusses how best to support tuberculosis patients in the developing world.
Chair seeks to tackle bias in WHO swine flu review
Frank Jordans of the Associated Press quotes IPN's Philip Stevens on the WHO swine flu review
WHO: Not sure if drug-resistant TB is worsening
IPN News coverage
Philip Stevens responds to the WHO's statement on drug-resistant TB.
Health as a human right: the wrong prescription
Tuesday, December 29, 2009
Should healthcare be a human right?
WHO: Treat HIV patients sooner
IPN News coverage
Philip Stevens comments on new HIV treatment advice from the WHO
UN: 4 million on AIDS drug, others still in need
IPN News coverage
IPN's Philip Stevens comments on the World Health Organization's latest HIV treatment report.
